CHERYL V. REICIN, J.D.

Cheryl Reicin is the chair of Torys’ Life Science Group, a cross-border group in both Canada and the U.S.,. Prior to joining Torys, Ms. Reicin led the 85 attorney life science group of a US law firm. She has the sole distinction of being ranked in international and national rankings as a leading lawyer in life sciences in both the US and Canada and has received numerous recognitions and awards, including, among others, LMG Life Science’s Finance & Transactional Lawyer of the Year; Best Lawyers in Canada – Life Science Lawyer of the Year and Best of the Best – Leading Lawyer in Life Science, Canada’s Top 25 Women of Influence and the Hall of Fame of Canada's 100 Most Powerful Women.


Cheryl Reicin is one of the leading practitioners in the life science area globally, having represented more than 750  companies. She publishes and speaks extensively throughout North America and abroad. Cheryl’s practice focuses on biotechnology, medical device, health information and other technology-based companies, and representation of private equity/venture capital funds and investment banks that fund such companies. She also represents academic medical centers and universities. Her practice centers on U.S., Canadian, Israeli, European and Chinese entities.


Cheryl represents the whole spectrum of life science companies from inception to multibillion transactions. She advises on seed, venture and later-stage financings, IPOs, mergers acquisitions, complex licensing transactions and joint venture or alliances with strategic partners. She also coordinates domestic and international corporate structuring.


Ms. Reicin is involved in numerous charitable endeavors, including, among others, serving as a trustee for The Hospital for Sick Children, a director of The SickKids Foundation, the chair and Founder of Genesis UJA, a member of the business advisory board of the Institute for the Study of Aging, Dean’s Special Advisory Board (York University Faculty of Science) and HarbourVest Canada Industry and a founder of Canadian Women in Life Sciences.


She is a summa cum laude graduate of Barnard College, Columbia University and the Harvard Law School.